[ Meeting Rosters ]

The Clinical Hematology Special Emphasis Panel [SEP] reviews applications proposing single-site clinical studies related to inherited blood disease (including gene therapy or genetics), or relating to red blood cell/monocyte/leukocyte biology, hematopoiesis, hemostasis and thrombosis, or inflammation. Multi-center clinical trials are not appropriate for this panel.

Study sections with most closely related areas of similar science listed in rank order are:

Erythrocyte and Leukocyte Biology [ELB]  
Hemostasis and Thrombosis [HT] 
Innate Immunity and Inflammation [III]  
Hematopoiesis [HP]